PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sandeep Jain PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Rajesh Jain PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated August 25, 2020 intimating the date of proposed Board Meeting scheduled to be held on September 03, 2020, for approving the Standalone and Consolidated Unaudited Financial Results (Provisional) for the Quarter ended June 30, 2020 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the notice of Board Meeting published in the following newspapers on August 26, 2020:- Business Standard (English); Desh Sewak (Punjabi) This is for your kind information and record please. PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated August 25, 2020 intimating the date of proposed Board Meeting scheduled to be held on September 03, 2020, for approving the Standalone and Consolidated Unaudited Financial Results (Provisional) for the Quarter ended June 30, 2020 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the notice of Board Meeting published in the following newspapers on August 26, 2020:- Business Standard (English); Desh Sewak (Punjabi) This is for your kind information and record please. PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter Ended June 30, 2020
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2020 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30, 2020. Further, with reference to our earlier announcement dated June 30, 2020 intimating the Closure of Trading Window pursuant to the Company's Code of Conduct. for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company and Material Subsidiaries of the Company till September 05, 2020. PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Dear Sir/Madam, This is in continuation to our earlier intimation letters dated June 10, 2020 and June 16, 2020 regarding Memorandum of Understanding ('MOU') dated June 09, 2020 entered into between the Company and REFANA Inc. USA, a Delaware corporation incorporated under the laws of the state of Delaware, United States for global development, manufacturing and distribution of the Covid-19 vaccine, through a 50:50 Joint Venture Company. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we would like to inform you that the Company has terminated the MOU with effect from August 21, 2020. The detailed disclosure as required under Regulation 30 of SEBI LODR Regulations in respect of the above mentioned termination is annexed herewith. PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we are pleased to inform you that Hon''ble National Company Law Tribunal, Chandigarh Bench ("NCLT") vide its dictating order dated August 17, 2020, which became available on the NCLT website on August 18,2020, has reserved its order in the Scheme of Arrangement. Copy of the dictating order, as available on the NCLT website, is enclosed herewith. The detailed order of the Hon''ble NCLT in the Scheme of Arrangement is awaited. We shall update you accordingly. PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is with reference to CDSL''s Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of July, 2020. PANACEA BIOTEC LTD. - 531349 - Disclosure Of Material Impact Of Covid-19 Pandemic On The Company Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 read with SEBI Circular NO.SEBIIHO/CFD/CMDlICIRIP/2020/84 dated May 20, 2020 regarding disclosure of material impact of novel coronavirus (Co VID - 19) outbreak and pandemic status on operations of the Company, please find enclosed herewith the required details as per Annexure 1. PANACEA BIOTEC LTD. - 531349 - Disclosure Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find enclosed disclosures of related party transactions in the format specified in the relevant accounting standards for half year ended March 31, 2020 on consolidated basis.